Latest Videos

Industry Perspective – From Science to Clinical Utility: The Role of Cxbladder in the Diagnosis and Management of Bladder Cancer

Industry Perspective – From Science to Clinical Utility: The Role of Cxbladder in the Diagnosis and Management of Bladder Cancer

Posted by | Oct 2022

In this 17-minute video sponsored by Pacific Edge Diagnostics, Tamer Aboushwareb, MD, PhD, Vice President of Medical Affairs for Pacific Edge Diagnostics, discusses the role of the Cxbladder test in improving the diagnosis, treatment, and management of bladder cancer, including lowering costs, improving physician workflow, and helping to avoid invasive cystoscopic procedures.

Read More
Genetic Testing for Identifying Who is at Risk of Prostate Cancer and Lethal Cancer

Genetic Testing for Identifying Who is at Risk of Prostate Cancer and Lethal Cancer

Posted by | Oct 2022

Jianfeng Xu, MD, DrPH, Vice President of Translational Research at NorthShore University HealthSystem (NorthShore), the Ellrodt-Schweighauser Family Chair of Cancer Genomic Research, Director of the Program for Personalized Cancer Care (PPCC) at NorthShore, and a Research Professor at the University of Chicago Pritzker School of Medicine, discusses the role of genetic testing in prostate cancer risk identification. Dr. Xu discusses who is at elevated risk for prostate cancer, the relationship among three inherited risk factors (family history [FH], monogenic rare pathogenic mutations [RPMs], and polygenic genetic risk score [GRS]), the idea that monogenic and polygenic may be tested at the same time, key challenges for germline testing, and the improvement of current guidelines for prostate cancer early detection.

Read More
Brachytherapy: The Royal Flush of Radiation Treatment for Men with High-Risk Prostate Cancer

Brachytherapy: The Royal Flush of Radiation Treatment for Men with High-Risk Prostate Cancer

Posted by | Oct 2022

Mira Keyes, MD, FRCPC, a Clinical Professor at the University of British Columbia (UBC) and a radiation oncologist at the Vancouver Centre of the British Columbia Cancer Agency (BCCA), discusses the benefits of prostate brachytherapy (PB) for men with high- and very high-risk prostate cancer. Dr. Keyes explains PB has excellent long-term outcomes (with the best cure rates of all radiation therapy [RT] treatments), requires less androgen deprivation therapy (ADT), has less downstream toxicity and lower cost than alternatives, calling it a “royal flush” treatment when used as a boost with external beam radiation therapy (EPRT).

Read More
Mutliparametric MRI for Solid Masses: Accurate Detection of Clear Cell Renal Cell Carcinoma to Direct Patient Care

Mutliparametric MRI for Solid Masses: Accurate Detection of Clear Cell Renal Cell Carcinoma to Direct Patient Care

Posted by | Oct 2022

Jeffrey A. Cadeddu, MD, Ralph C. Smith, MD, Distinguished Chair in Minimally Invasive Urologic Surgery, Director of The University of Texas (UT) Southwestern Clinical Center for Minimally Invasive Treatment of Urologic Cancer, and Professor of Urology and Radiology at UT Southwestern Medical Center in Dallas, Texas, discusses multiparametric magnetic resonance imaging (mpMRI) for small renal masses (SRM). Dr. Cadeddu emphasizes the use of mpMRI and a clear cell likelihood score (ccLS) as a promising, reliable, non-invasive, and cost-effective means of renal tumor characterization that can eliminate the need for biopsy in most patients.

Read More

Join the GRU Community

- Why Join? -